Houlihan Financial Resource Group’s GSK GSK Stock Holding History

Houlihan Financial Resource Group’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	$16K	Buy	+320	New	+$16K	0.01%	248

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

BCIM

Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return

Houlihan Financial Resource Group's GSK Position: Q3 2020 in Review

Houlihan Financial Resource Group opened a new position in GSK (GSK) in Q3 2020: 320 shares worth $16K. The stake represents 0.01% of the portfolio and ranks #248 among its holdings.

826 funds tracked by Wall St. Rank hold GSK as of Q3 2020.

Houlihan Financial Resource Group held 320 shares of GSK worth $16K as of Q3 2020.
GSK was a new Houlihan Financial Resource Group position in Q3 2020.
GSK made up 0.01% of Houlihan Financial Resource Group's portfolio in Q3 2020, its #248 holding.
826 funds tracked by Wall St. Rank held GSK as of Q3 2020.

Based on Houlihan Financial Resource Group's 13F filing for Q3 2020, filed 13 Nov 2020.